`________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`________________
`
`LG ELECTRONICS INC.,
`Petitioner,
`
`v.
`
`IMMERVISION, INC.,
`Patent Owner.
`____________
`
`U.S. Patent No. 6,844,990
`____________
`
`DECLARATION OF RUSSELL CHIPMAN, PH.D.
`IN SUPPORT OF PETITIONER’S REPLY TO PATENT OWNER’S
`RESPONSE TO PETITION FOR INTER PARTES REVIEW OF U.S.
`PATENT NO. 6,844,990
`
`LGE Exhibit 1019
`LGE v. ImmerVision - IPR2020-00179
`Page 1 of 21
`
`
`
`Reply Declaration of Dr. Russell Chipman
`Case Nos. IPR2020-00179, -00195
`U.S. Patent No. 6,844,990
`
`
`
`TABLE OF CONTENTS
`
`I. Background And Qualifications ........................................................................ 1
`II. Tada Renders Claims 5 and 21 Obvious ............................................................ 3
`III. Tada in View of Baker Renders Claims 5 And 21 Obvious ............................ 13
`IV. Tada in View of Nagaoka Renders Claims 5 And 21 Obvious ....................... 16
`V. Conclusion ....................................................................................................... 18
`
`
`i
`
`LGE Exhibit 1019
`LGE v. ImmerVision - IPR2020-00179
`Page 2 of 21
`
`
`
`Reply Declaration of Dr. Russell Chipman
`Case Nos. IPR2020-00179, -00195
`U.S. Patent No. 6,844,990
`
`
`I, Russell Chipman, hereby declare the following:
`
`I.
`
`BACKGROUND AND QUALIFICATIONS
`1. My name is Russell Chipman and I am over 21 years of age and
`
`otherwise competent to make this Declaration. I make this Declaration based on
`
`facts and matters within my own knowledge and on information provided to me by
`
`others, and, if called as a witness, I could and would competently testify to the
`
`matters set forth herein.
`
`2.
`
`I have been retained as a technical expert witness in this matter by
`
`Counsel for Petitioner LG Electronics Inc. to provide my independent opinions on
`
`certain issues requested by Counsel for Petitioner relating to the petitions for Inter
`
`Partes Review of U.S. Patent No. 6,844,990 (“the ’990 Patent”). My compensation
`
`in this matter is not based on the substance of my opinions or the outcome of this
`
`matter. I have no financial interest in Petitioner. I have been informed that
`
`ImmerVision, Inc. (“ImmerVision”) is the purported owner of the ’990 Patent, and
`
`I note that I have no financial interest in ImmerVision.
`
`3.
`
`I previously provided a declaration dated November 27, 2019, in
`
`support of the petitions for inter partes review of claims 5 and 21 of the ’990
`
`Patent (Ex. 1008). I summarized my educational background, career history, and
`
`other qualifications relevant to this matter in my prior declaration. I also
`
`previously provided my curriculum vitae as Appendix A to my prior declaration
`
`1
`
`LGE Exhibit 1019
`LGE v. ImmerVision - IPR2020-00179
`Page 3 of 21
`
`
`
`Reply Declaration of Dr. Russell Chipman
`Case Nos. IPR2020-00179, -00195
`U.S. Patent No. 6,844,990
`
`
`(Ex. 1009). Finally, I provided a declaration (Ex. 1017) regarding certain Code V
`
`exhibits (Exs. 1014-1016).
`
`4.
`
`Since submitting my November 27, 2019, declaration, I have
`
`reviewed the following documents in this proceeding:
`
` Patent Owner’s Preliminary Response (Paper No. 5)
`
` Decision Granting Institution (Paper No. 6)
`
` Exhibits 1014-1016
`
` Patent Owner’s Response (Paper No. 12)
`
` Exhibits 2001-2022, which includes the Declaration of Mr. Aikens
`
`(Exhibit 2009)
`
` October 1, 2020, Transcript of the Deposition of Mr. David Aikens
`
`(Exhibit 1018)
`
` K-10 Glass Data Sheet, Schott North America, Inc. (Exhibit 1020)
`
` Definition of “embodiment,” Black’s Law Dictionary (11th ed. 2019)
`
`(Exhibit 1021)
`
` Optikos® LensCheckTM VIS Lens Measurement System Datasheet
`
`(Exhibit 1022)
`
`2
`
`LGE Exhibit 1019
`LGE v. ImmerVision - IPR2020-00179
`Page 4 of 21
`
`
`
`Reply Declaration of Dr. Russell Chipman
`Case Nos. IPR2020-00179, -00195
`U.S. Patent No. 6,844,990
`
`
`II. TADA RENDERS CLAIMS 5 AND 21 OBVIOUS
`5.
`I disagree with Mr. Aikens that the purported error in Table 5 was
`
`“readily apparent.” Ex. 2009, ¶¶53-77, 132-136, 144-148. I also disagree with Mr.
`
`Aikens’s premise that a POSA would only be interested in recreating Tada’s exact
`
`lens models, rather than the explanations that Tada provides for wide-angle lenses
`
`and everything else it discloses. Ex. 2009, ¶43. There is nothing in Table 5 that
`
`would lead a POSA to believe there is an error because it includes all of the
`
`information necessary to enable a complete lens. I also disagree with Mr. Aikens
`
`that a POSA would always check the Table 5 data using the sag information in
`
`Table 6. Ex. 2009, ¶61. There would have been no reason to do so since the Table
`
`5 information is complete and stands on its own. Moreover, contrary to Mr.
`
`Aikens’s suggestion, sag information would not have been used for this purpose.
`
`As I previously testified, a sag table is typically only used in the fabrication
`
`process, not to check modeled lenses. See Ex. 2002 at 44:12-45:9.
`
`6.
`
`Even if a POSA were to check Table 5 with other parts of Tada, it
`
`would have taken many hours to conclude there was an error, as it did for Mr.
`
`Aikens himself. Ex. 1018 at 132:1-15, 136:5-137:12 (“I had figured out that
`
`something was wrong probably within two to three hours. Then modeling the
`
`other embodiments, that took time. And then continuing to try to understand how
`
`to recreate the surface, that took more time.”). In other words, the purported error
`
`3
`
`LGE Exhibit 1019
`LGE v. ImmerVision - IPR2020-00179
`Page 5 of 21
`
`
`
`Reply Declaration of Dr. Russell Chipman
`Case Nos. IPR2020-00179, -00195
`U.S. Patent No. 6,844,990
`
`
`that Mr. Aikens alleges is not obvious on its face and detectable with little effort.
`
`In order to point out the alleged error, Mr. Aikens had to spend many hours, going
`
`through a convoluted process that not only relied upon numerous uncalled for
`
`assumptions, but, in any event was unnecessary. As such, in my opinion any
`
`purported “error” in Table 5 of Tada would not have been an error obvious to one
`
`of ordinary skill in the art.
`
`7.
`
`In my opinion, Table 5 describes the claimed invention to a POSA,
`
`and a POSA would have been able to make the Table 5 lens as of that time based
`
`on his own knowledge and the teachings of Tada. I previously explained in my
`
`prior declaration how Tada’s Table 5 provides a lens that describes the claimed
`
`invention. Ex. 1008, ¶¶43-72. I also explained how Tada’s Table 5 teaches those
`
`skilled in the art to reconstruct a lens without undue experimentation (see, e.g., Ex.
`
`1008, ¶¶46, 50-53); thus, meeting the enablement requirement on its own.
`
`8.
`
`For example, a POSA could have reduced the Tada “Table 5” lens to
`
`practice without referring to any other tables, which Mr. Aikens admits are only
`
`used in manufacturing or to double check Table 5. As I explained in my
`
`deposition, Tada’s Table 5 included all of the information needed for my Code V
`
`analysis to reconstruct the lens and calculate the image point distribution function.
`
`Ex. 2002 at 16:21-19:10. The information from the other Tables of embodiment 3
`
`were simply unnecessary. In my prior declaration, I explained how I entered the
`
`4
`
`LGE Exhibit 1019
`LGE v. ImmerVision - IPR2020-00179
`Page 6 of 21
`
`
`
`Reply Declaration of Dr. Russell Chipman
`Case Nos. IPR2020-00179, -00195
`U.S. Patent No. 6,844,990
`
`
`information from Table 5 into Code V in order to perform my analysis. See, e.g.,
`
`Ex. 1008, ¶46.
`
`9.
`
`In my opinion, the lens described in Table 5 of Tada meets all of the
`
`conditions that Tada discloses are desirable. For example, the Table 5 lens meets
`
`conditions 2-4 at the top of column 2, which Patent Owner concedes are the
`
`requirements set out by Tada. See PO Resp. at 10. Moreover, Tada discloses in
`
`Table 5 a lens that meets all of the elements of claims 5 and 21. As such, the Table
`
`5 lens is its own embodiment. My understanding is that an “embodiment” is
`
`simply “a specific physical form of the invention.” Embodiment, Black’s Law
`
`Dictionary (11th ed. 2019) (Ex. 1021). In my opinion, Table 5 of Tada alone
`
`meets that definition, and is therefore its own embodiment of Tada.
`
`10. Mr. Aikens criticizes my analysis of Tada over the full spectrum of
`
`visible light and argues that I should have focused only on the d-, g-, and c-lines,
`
`given as examples in Tada, rather than the full spectrum of visible light. Ex. 2009,
`
`¶¶78-101. I disagree. There is nothing in the ’990 Patent or Tada that limits the
`
`lens to be used only with light having those wavelengths, nor would it even make
`
`sense. Instead, Tada states the lens is used for a monitoring camera (CCTV). Ex.
`
`1007 at 1:7-9. Cameras used for monitoring need to capture most, if not all, of the
`
`full spectrum of visible light to be effective.
`
`5
`
`LGE Exhibit 1019
`LGE v. ImmerVision - IPR2020-00179
`Page 7 of 21
`
`
`
`Reply Declaration of Dr. Russell Chipman
`Case Nos. IPR2020-00179, -00195
`U.S. Patent No. 6,844,990
`
`11. As such, a POSA would have evaluated the lens at a full range of
`
`
`
`wavelengths of visible light. Indeed, it would have been negligent for a POSA
`
`designing a lens for use in the visible light spectrum not to analyze the lens across
`
`the full spectrum. In the corresponding district court litigation, Patent Owner
`
`appears to have analyzed infringement of claims 5 and 21 using light throughout
`
`the visible spectrum, rather than at one or two wavelengths, when it relied on real
`
`images in the full visible spectrum. See generally Ex. 1010; Ex. 1011. It is also
`
`worth noting that Patent Owner stated that its infringement analysis was performed
`
`using an Optikos® LensCheckTM VIS machine (Ex. 1010 at 2; Ex. 1011 at 2),
`
`which uses a light source of 400-700nm (i.e., the majority of the visible spectrum)
`
`and has spectral sensitivity of 400-1000nm (Ex. 1022 at 3). Accordingly, Patent
`
`Owner appears to agree that the full spectrum of visible light should be used when
`
`evaluating whether the elements of claims 5 and 21 are met.
`
`12.
`
`I strongly disagree with Mr. Aikens’s assertion that “it is suspect for
`
`Dr. Chipman to conduct his analysis at any wavelength other than the Helium d-
`
`line, which has been identified by Tada in Table 5 as the reference wavelength of
`
`the spectrum.” Ex. 2009, ¶87. Tada discloses sufficient information for an
`
`analysis of visible light wavelengths across the spectrum. Table 5 specifies the
`
`Abbe number and the refractive index of the lens system. These numbers are all
`
`6
`
`LGE Exhibit 1019
`LGE v. ImmerVision - IPR2020-00179
`Page 8 of 21
`
`
`
`Reply Declaration of Dr. Russell Chipman
`Case Nos. IPR2020-00179, -00195
`U.S. Patent No. 6,844,990
`
`
`the information needed for a lens modeling program, such as Code V or Zemax, to
`
`model the performance of the lens at multiple wavelengths.
`
`13. Even assuming it is necessary to analyze Tada’s teachings with
`
`respect to real-world lens materials, which I believe is not necessary, Tada’s Table
`
`5 lens still meets the claims. Mr. Aikens opines that the material of the lens in
`
`Tada is likely PMMA and that “[a]t 380 nm, a 2 mm thick sample transmits only
`
`50%” of the received radiation. Ex. 2009, ¶¶80, 82. First, I note that Tada does
`
`not specify the specific material of the lens and Mr. Aikens does not allege
`
`otherwise. Second, Aikens’ analysis ignores that there were other types of well-
`
`known materials with similar Abbe and index numbers, such as K-10 glass (Schott
`
`North America, Inc.), that are better transmitters at 380nm (over 90%, rather than
`
`50%). Ex. 1020. More importantly, Mr. Aikens acknowledges that even PMMA
`
`allows at least some transmission of light across the full spectrum, which is all that
`
`is required to meet all of the elements of claims 5 and 21, since a particular level of
`
`transmission is not specified in the claims.
`
`14. Although Mr. Aikens criticizes my analysis as being focused on the
`
`use of light at 380 nm, I previously analyzed the full visible spectrum of light, and
`
`at most, there was less than 2% difference between Tada’s maximum divergence
`
`and the claim’s ±10%, a difference that I have previously explained would have
`
`been well within the skill of a POSA to increase to 10%. Ex. 1008, ¶52 (noting
`
`7
`
`LGE Exhibit 1019
`LGE v. ImmerVision - IPR2020-00179
`Page 9 of 21
`
`
`
`Reply Declaration of Dr. Russell Chipman
`Case Nos. IPR2020-00179, -00195
`U.S. Patent No. 6,844,990
`
`
`analysis at six different wavelengths across the visible spectrum); id., ¶¶57 n.2, 61.
`
`Moreover, at the d-line (587.56 nm), which Mr. Aikens (incorrectly) argues is the
`
`only wavelength that should be used, the maximum divergence is 8.43%, which is
`
`only 1.57% less than the claimed ±10%. See Ex. 1013 at 18 (green highlighted
`
`row). This amount is sufficient to meet the claims ±10% limitation and Mr.
`
`Aikens has not argued otherwise.
`
`15. Mr. Aikens states that “[n]owhere in Tada is there any mention of an
`
`image distribution function, by that or any other name.” Ex. 2009, ¶103. First,
`
`Mr. Aikens admits that the term “image point distribution function” is not a term of
`
`art (Ex. 1018 at 70:22-71:2), so it is no surprise that these words are not mentioned
`
`in Tada. Instead, Tada contains distortion plots (e.g., Figs. 4, 9, 14, 19), which
`
`convey information to a POSA about the compression and expansion
`
`characteristics of a lens, i.e., the same information that the “image point
`
`distribution function” provides. Additionally, as the Board has already noted,
`
`Tada’s lens contains the same characteristics as the claimed lens, no matter what
`
`new terms the inventors made-up to describe the inherent characteristics of a lens.
`
`Institution Decision (Paper 6) at 21 (IPR2020-00179) and 21-22 (IPR2020-00195)
`
`(noting with respect to the ±10% limitation that “there is no need for the
`
`calculation if the limitation simply follows as a consequence of a lens system that
`
`is otherwise rendered obvious by Tada’s third embodiment such that the limitation
`
`8
`
`LGE Exhibit 1019
`LGE v. ImmerVision - IPR2020-00179
`Page 10 of 21
`
`
`
`Reply Declaration of Dr. Russell Chipman
`Case Nos. IPR2020-00179, -00195
`U.S. Patent No. 6,844,990
`
`
`is met.”). In other words, by plugging the inherent properties of the lens in Tada’s
`
`Table 5 into the disclosed equation for the image point distribution function,
`
`Tada’s Table 5 embodiment meets the claimed characteristics of claims 5 and 21
`
`(compressionexpansioncompression of the image and a 10% maximum
`
`divergence).
`
`16. Next, Dr. Aikens argues that the image point distribution function
`
`should have been calculated using a centroid analysis rather than using the chief
`
`ray heights. Ex. 2009, ¶¶107-120. I disagree. Neither the claims nor the
`
`specification of the ’990 Patent require a centroid analysis. Moreover, to a POSA,
`
`use of chief rays would have been a standard form of analysis and a common way
`
`to analyze the performance of a lens. Indeed, chief rays are used to plot distortion
`
`curves typically used by a POSA to convey information about the compression and
`
`expansion of a lens.
`
`17. Further, calculating the centroids requires a POSA to make additional
`
`assumptions about the lens, e.g., with respect to lens apertures and vignetting. The
`
`necessary information is not included in Tada (or the ’990 Patent) because it varies
`
`depending on the actual real-world construction of the lens, and it can only be
`
`partially estimated from the figures, which in any event are not drawn to scale.
`
`Mr. Aikens testified that he could not “exactly recreate[] [Tada’s] vignetting,” so
`
`9
`
`LGE Exhibit 1019
`LGE v. ImmerVision - IPR2020-00179
`Page 11 of 21
`
`
`
`Reply Declaration of Dr. Russell Chipman
`Case Nos. IPR2020-00179, -00195
`U.S. Patent No. 6,844,990
`
`
`he just tweaked his model in Zemax and “eyeballed” the output until it appeared to
`
`match Figure 11 of Tada. Ex. 1018 at 223:22-226:19, 229:16-230:5. Moreover,
`
`the ’990 Patent does not mention a centroid analysis. Therefore, performing a
`
`centroid analysis, as compared to a chief-ray analysis, neither is supported by the
`
`’990 Patent nor makes sense since the information needed to account for vignetting
`
`was not provided by the reference and instead added by Mr. Aikens. In addition,
`
`the result of the centroid analysis can vary depending on how it is performed, for
`
`example, depending on how many rays a person uses to perform the analysis.
`
`18.
`
`In addition, even if the claims require a maximum divergence of
`
`exactly 10.0% or greater, Mr. Aikens’s calculated maximum divergence of 7.6% is
`
`well within routine optimization of ±10%. Adding a few percentage points of
`
`divergence to the maximum divergence of the lens system of Tada’s third
`
`embodiment would have been well within the skill of a POSA and would have
`
`been undertaken as part of routine engineering optimization techniques with a
`
`reasonable expectation that it would have led to further improved definition in the
`
`intermediate zone while maintaining acceptable image quality. A POSA would
`
`have used a software program such as Code V to assist with this routine
`
`optimization, as explained below. Mr. Aikens confirmed as much when he
`
`testified that “[o]nce you know what you’re trying to do, it’s actually not that hard
`
`to manipulate the lens to get it to do what you want.” Ex. 1018 at 192:15-195:14.
`
`10
`
`LGE Exhibit 1019
`LGE v. ImmerVision - IPR2020-00179
`Page 12 of 21
`
`
`
`Reply Declaration of Dr. Russell Chipman
`Case Nos. IPR2020-00179, -00195
`U.S. Patent No. 6,844,990
`
`19. Accordingly, in my opinion, Tada still renders claims 5 and 21
`
`
`
`obvious under PO’s “corrected” analysis.
`
`20. Mr. Aikens argues that “a POSA would turn to Tada specifically to
`
`reduce [distortion].” Ex. 2009, ¶125; see also PO Resp. at 57. While that may be
`
`one aspect of Tada, it is not the only improvement that Tada teaches to a POSA,
`
`especially since that aspect was focused on the surface of just one particular lens
`
`element, namely the second one. Ex. 1007 at 1:39-44. As such, Tada was focused
`
`on constraining certain characteristics of the surface of the second lens element
`
`(Ex. 1007 at 2:7-28), but there are many other lens elements that could have been
`
`modified to increase the maximum divergence and still be in line with Tada’s
`
`goals.
`
`21.
`
`It is undisputed that Tada’s Table 5 embodiment teaches a lens that
`
`has the claimed characteristics of compressing the center and edges of the image
`
`and expanding an intermediate zone of the image. Regardless of whether the Table
`
`5 embodiment was what Mr. Aikens calls a “mistake,” it still satisfies all of the
`
`goals and conditions specified in Tada. A POSA would have undertaken as part of
`
`routine engineering optimization techniques with a reasonable expectation that it
`
`would have led to further improved definition in the intermediate zone while still
`
`meeting all of Tada’s requirements, as I explained in my prior declaration. Ex.
`
`1008, ¶¶60-61. For example, a POSA would have indicated the desired chief ray
`
`11
`
`LGE Exhibit 1019
`LGE v. ImmerVision - IPR2020-00179
`Page 13 of 21
`
`
`
`Reply Declaration of Dr. Russell Chipman
`Case Nos. IPR2020-00179, -00195
`U.S. Patent No. 6,844,990
`
`
`height distributions (or centroid height distributions) in Code V that would lead to
`
`a further expansion of the intermediate zone and would have indicated which lens
`
`element’s surfaces could be changed to allow for the changes in the chief ray
`
`height distributions. Ex. 1008, ¶61. I previously described the analysis with
`
`respect to the chief ray height distributions, but the analysis would be very similar
`
`if one were to use, as Mr. Aikens proposes, the centroid height distributions instead
`
`of chief ray heights. Code V could be set up to calculate the centroid height
`
`distributions as Mr. Aikens proposes, then a POSA could indicate the desired
`
`centroid height distributions, rather than the desired chief ray height distributions,
`
`and the analysis I previously described would be virtually the same.
`
`22. As noted in my prior declaration, a POSA would have indicated which
`
`lens’s surfaces could be changed to allow for the changes in the chief ray (or
`
`centroid) height distributions. Ex. 1008, ¶61. Therefore, a POSA would have set
`
`the surfaces of the second lens element constant in Code V so as to align with
`
`Tada’s goals. The program would then calculate the changes to the lenses to
`
`provide for the requested chief ray (or centroid) height distribution while
`
`maximizing image quality. Ex. 1008, ¶61. Again, as Mr. Aikens testified, “it’s
`
`actually not that hard to manipulate the lens to get it to do what you want.” Ex.
`
`1018 at 192:15-195:14.
`
`12
`
`LGE Exhibit 1019
`LGE v. ImmerVision - IPR2020-00179
`Page 14 of 21
`
`
`
`Reply Declaration of Dr. Russell Chipman
`Case Nos. IPR2020-00179, -00195
`U.S. Patent No. 6,844,990
`
`23. The ’990 Patent itself provides far less detail about the lens elements
`
`
`
`than Tada, so a POSA would have had a better starting point with Tada than with
`
`the disclosure of the ’990 Patent. For example, the ’990 Patent, unlike Tada,
`
`provides no aspherical coefficients or any detail about the structure of the lens.
`
`Instead, the ’990 Patent leaves the determination of the design of the lens to the
`
`POSA by using “classical computer-aided lens design tools,” such as Code V:
`
`The determination of the parameters defining the
`aspherical sides mentioned above, the formula of the
`diffraction grating of the lens L6, the calculation of the
`diameters of the lenses and of the distances between the
`lenses, are within the understanding of those skilled in
`the art using the classical computer-aided lens design
`tools.
`
`’990 Patent at 17:29-34.
`
`24. Accordingly, as the ’990 Patent itself acknowledges, designing a lens
`
`to have the claimed characteristics is nothing more than routine optimization using
`
`computer-aided lens design tools.
`
`III. TADA IN VIEW OF BAKER RENDERS CLAIMS 5 AND 21
`OBVIOUS
`25.
`In general, Baker teaches enhancing a portion of the image of interest
`
`at the expense of decreasing the image quality in areas of less interest.
`
`Specifically, Baker describes a lens for a teleconference imaging system where
`
`13
`
`LGE Exhibit 1019
`LGE v. ImmerVision - IPR2020-00179
`Page 15 of 21
`
`
`
`Reply Declaration of Dr. Russell Chipman
`Case Nos. IPR2020-00179, -00195
`U.S. Patent No. 6,844,990
`
`
`there is a hemispheric imaging system placed at a central point on a conference
`
`table with the camera pointed upward. Ex. 1005 at 1:52-58, 5:37-44; Ex. 1018 at
`
`120:10-123:4. In such a system, the image at the center, i.e., of the ceiling, is of
`
`little importance, while the image at the periphery, i.e., of the participants around
`
`the table, is the useful information. Although Baker was primarily concerned with
`
`video conferencing, it noted its teachings could be used in other systems that
`
`would employ hemispherical visual data, such as in security and surveillance, the
`
`same application in Tada. Ex. 1005 at 2:10-16.
`
`26. Mr. Aikens alleges that I made a “mistake by not considering all of
`
`Baker and ignor[ing] Baker’s express criticisms of lenses that do not expand the
`
`image at its edges.” Ex. 2009, ¶149. I strongly disagree and believe it is Mr.
`
`Aikens who is the one ignoring Baker’s explicit teachings.
`
`27. While true that Baker is generally concerned with enhancing the
`
`“periphery” of the lens, Baker also teaches enhancing an intermediate zone.
`
`Recognizing that the area of most interest is slightly above the horizon where
`
`people’s faces will be, Baker notes that the enhancement (i.e., expansion) can start
`
`at 10° above the horizon and go up to 30° or 45° above the horizon (i.e., either 60°
`
`or 45° to 80° from the center). See Ex. 1005 at 13:60-65; see also id. at 19:9-13
`
`(“The method as in claim 8, wherein said periphery-enhancing optical system
`
`selectively magnifies visual content within an arc of between 10 and 45 degrees
`
`14
`
`LGE Exhibit 1019
`LGE v. ImmerVision - IPR2020-00179
`Page 16 of 21
`
`
`
`Reply Declaration of Dr. Russell Chipman
`Case Nos. IPR2020-00179, -00195
`U.S. Patent No. 6,844,990
`
`
`up from the horizon in a hemispheric field of view onto the imager device.”)
`
`(emphasis added). When using the convention of the center of the lens being zero
`
`degrees (facing upward here), rather than the horizon, Baker teaches expanding
`
`between 60 and 80 degrees or 45 to 80 degrees in a lens with a 90-degree field
`
`angle. Mr. Aikens confirmed Baker’s embodiment where the lens pointing at the
`
`ceiling (zero degrees) enhances the area from 60-80 degrees, i.e., expands an
`
`intermediate zone. Ex. 1018 at 268:14-269:4. Because enhancing an image
`
`received by a finite image sensor is a zero-sum game, i.e., if the lens is expanded in
`
`one zone, it has to be compressed elsewhere, the center and edge of the lens must
`
`see less quality and be compressed. See, e.g., Ex. 1018 at 94:9-22 (Aikens
`
`confirming that for purposes of this case, the height of the image point distribution
`
`always starts at zero degrees at the center of the lens (0,0°) and end at the image
`
`height, normalized to 1 and the maximum field angle of the lens (1, 90°)).
`
`Therefore, a POSA would have understood that in order to enhance the area
`
`between 60° and 80° (from the center of the lens pointing at the ceiling), this
`
`intermediate zone is expanded, and the other zones (i.e., the center and edge) of the
`
`image are necessarily compressed. In other words, Baker’s teachings squarely
`
`align with Tada’s Table 5 and claim 5’s and claim 21’s limitation that “the
`
`[objective] lens compresses the center of the image [e.g., 0° to 60°] and the edges
`
`15
`
`LGE Exhibit 1019
`LGE v. ImmerVision - IPR2020-00179
`Page 17 of 21
`
`
`
`Reply Declaration of Dr. Russell Chipman
`Case Nos. IPR2020-00179, -00195
`U.S. Patent No. 6,844,990
`
`
`of the image [e.g., 80° to 90°] and expands an intermediate zone of the image [e.g.,
`
`60° to 80°] located between the center and the edges of the image.”
`
`28. Accordingly, Baker clearly would have motivated a POSA to further
`
`expand the intermediate zone of the Table 5 embodiment of Tada, and certainly
`
`does not teach away as PO contends. Also, as I mentioned in my prior declaration,
`
`Baker teaches a maximum divergence of 15.1%, well above the claimed ±10%.
`
`Ex. 1008 at ¶95.
`
`IV. TADA IN VIEW OF NAGAOKA RENDERS CLAIMS 5 AND 21
`OBVIOUS
`29. Mr. Aikens and Patent Owner argues that Nagaoka teaches away from
`
`enhancing an intermediate zone and Petitioner is “[m]otivated by hindsight” in
`
`selecting Tada’s intermediate zone for enhancement. Ex. 2009, ¶¶137-142; PO
`
`Resp. at 65. In its preliminary response, Patent Owner argued that Petitioner
`
`provided no evidence that a POSA would have found the importance of Tada’s
`
`intermediate zone. Prelim. Resp. at 33; see also Institution Decision at 31-32
`
`(IPR2020-00179) and 32 (IPR2020-00195) (noting PO’s argument). This is
`
`incorrect. A POSA would have recognized the importance of the expanded
`
`intermediate zone in Tada, including based on the teachings of Nagaoka. Nagaoka
`
`teaches that having a slope greater than that of a linear curve provides for
`
`additional data/enhancement and that having enhancement zones is useful. Ex.
`
`16
`
`LGE Exhibit 1019
`LGE v. ImmerVision - IPR2020-00179
`Page 18 of 21
`
`
`
`Reply Declaration of Dr. Russell Chipman
`Case Nos. IPR2020-00179, -00195
`U.S. Patent No. 6,844,990
`
`
`1004 at 2:43-53, 6:60-65. Therefore, a POSA would have recognized that the
`
`intermediate zone of Tada, which has a slope greater than that of a linear curve,
`
`would likewise provide enhancement of this intermediate region. In addition,
`
`Nagaoka further teaches: the greater the slope, the greater the benefit. For
`
`example, Nagaoka provides a number of non-linear curves as examples and notes
`
`that the curves with the greater slopes are more beneficial than those with less of
`
`an increase in slope. Id. at 5:61-6:15. In other words, Nagaoka teaches a POSA to
`
`attempt to maximize the slope of the curve, which would result in a greater
`
`maximum divergence.
`
`30. Mr. Aikens incorrectly alleges that Nagaoka teaches away from a
`
`combination with Tada. Ex. 2009, ¶142. Mr. Aikens’s opinion appears to be
`
`based on the belief that because Nagaoka explicitly discusses enhancing the
`
`periphery of the lens, a POSA would never compress the edges. See generally Ex.
`
`2009, ¶¶137-142. I believe this to be an oversimplification of Nagaoka and that it
`
`ignores the reality of the characteristics of the lenses disclosed in Nagaoka.
`
`31. A POSA seeking to improve on Tada’s lens design would have looked
`
`to other lens systems for CCTV cameras. Specifically, a POSA would look to
`
`other lens systems for CCTV cameras to see how much maximum divergence is
`
`possible for such lenses. Nagaoka teaches that it is desirable to have a lens system
`
`for CCTV cameras with a maximum divergence much larger than what Tada
`
`17
`
`LGE Exhibit 1019
`LGE v. ImmerVision - IPR2020-00179
`Page 19 of 21
`
`
`
`Reply Declaration of Dr. Russell Chipman
`Case Nos. IPR2020-00179, -00195
`U.S. Patent No. 6,844,990
`
`
`discloses. Nagaoka teaches the tradeoff of expanding the portion of the lens in the
`
`area of interest at the expense of compressing the portion of the image (the center
`
`here) that is less important. The fact that Nagaoka teaches two zones (compression
`
`and expansion) while Tada teaches three zones like claims 5 and 21 (compression,
`
`expansion, compression) is immaterial for a POSA looking for guidance on
`
`possible maximum divergence for lenses for CCTV cameras. As Mr. Aikens
`
`testified, a POSA could easily start from a lens design having compression at the
`
`center and expansion at the edge like the lens of Figure 15 of the ’990 Patent (and
`
`Nagaoka) and modify it to have the characteristics of the claimed invention (and
`
`Tada) (compression, expansion, and compression). Ex. 1018 at 192:16-195:14.
`
`Mr Aikens went further to state that the two lenses would not look much different
`
`from each other. Id. at 196:18-197:7.
`
`32. Accordingly, in my opinion, Nagaoka would have motivated a POSA
`
`to try to further expand the intermediate zone of the Table 5 embodiment of Tada.
`
`V. CONCLUSION
`33. For the reasons set forth above and in my prior declaration, in my
`
`opinion, claims 5 and 21 of the ’990 Patent are obvious in light of the prior art.
`
`
`
`
`
`18
`
`LGE Exhibit 1019
`LGE v. ImmerVision - IPR2020-00179
`Page 20 of 21
`
`
`
`Reply Declaration of Dr. Russell Chipman
`Case Nos. IPR2020-00179, -00195
`US. Patent No. 6,844,990
`
`34.
`
`I declare thatall statements made herein of my knowledgeare true,
`
`and that all statements made on information and belief are believed to be true, and
`
`that these statements were made with the knowledgethatwillful false statements
`
`and the like so made are punishable by fine or imprisonment, or both, under
`
`Section 1001 of Title 18 of the United States Code.
`
`Executed on October 26, 2020 in Tucson, Arizona.
`
`Craodl
`
`Russell Chipmas, Ph.D.
`
`\9
`
`
`
`LGE Exhibit 1019
`LGE v. ImmerVision - IPR2020-00179
`Page 21 of 21
`
`LGE Exhibit 1019
`LGE v. ImmerVision - IPR2020-00179
`Page 21 of 21
`
`